Zobrazeno 1 - 10
of 11
pro vyhledávání: '"R J, Paridaens"'
Publikováno v:
Anticancer research. 6(4)
The B6D2F1 mouse mammary adenocarcinoma was adapted to grow in vitro as monolayer. After in vitro passaging of tumor cells, phenotypic changes occurred that were expressed in vivo. Following intraperitoneal inoculation of tumor cells, bone-forming tu
Publikováno v:
Journal of the National Cancer Institute. 74(6)
The effects of a single 17 beta-estradiol (E2) injection on cell proliferation were studied in 3 groups of 30 mice transplanted with the MXT ovary-dependent mammary tumor. In group A, all animals were castrated prior to tumor implantation; groups B a
Publikováno v:
Journal of the National Cancer Institute. 78(3)
With the use of an in vivo tritiated thymidine ([3H]dThd) nuclear labeling followed by autoradiography, the effects at different times before sacrifice of single or paired injections of 17 beta-estradiol (E2) and/or progesterone (Pg), at different co
Publikováno v:
Journal of the National Cancer Institute. 77(1)
The transplantable MXT mouse mammary tumor is an experimental model for which the growth is modulated by ovarian hormones; because of scant knowledge about the effects of progesterone (Pg) alone on cancer cells, the present investigation was made. By
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 91
Autor:
R, Kiss, Y, de Launoit, M, L'Hermite-Balériaux, M, L'Hermite, R J, Paridaens, A J, Danguy, J L, Pasteels
Publikováno v:
Journal of the National Cancer Institute. 78(5)
With the use of an in vivo tritiated thymidine [( 3H]dThd) nuclear labeling followed by autoradiography, the effects at different times before sacrifice of prolactin (PRL) and/or 17 beta-estradiol (E2) were studied in C57BL X DBA/2f)F1 mice given tra
Publikováno v:
Cancer surveys. 5(3)
Autor:
M J, Piccart, R J, Paridaens
Publikováno v:
Revue medicale de Bruxelles. 9(5)
Publikováno v:
Anticancer research. 6(4)
In this study we compared the effects of either Aminoglutethimide (AGL) or Tamoxifen (TAM) therapy on the genital tract of postmenopausal women with advanced breast cancer. Thus, 15 patients treated with AGL, and 10 patients treated with TAM underwen
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 91